Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. 1994

B F Ramos, and Y Zhang, and B A Jakschik
Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110.

Previous investigations in our laboratory have shown that mast cells play a significant role in the initiation of immune complex-mediated inflammation. Histamine, leukotrienes, and TNF released from mast cells are important mediators of early inflammatory processes. In the peritoneal reverse passive Arthus reaction, we observed a biphasic release of TNF. Mast cells were responsible for the first peak. The complement system is also known to be central to the expression of antibody-induced immune injury. Therefore, in this study, we investigated the significance of activated complement in regulating mast cell stimulation and neutrophil recruitment in the peritoneal reverse passive Arthus reaction. Mast cell degranulation and the release of TNF during the initiation of inflammation were blocked by decomplementation and C5 deficiency. Mast cell degranulation later in the reaction was complement-independent. Therefore, mast cells were activated in vivo in antibody-mediated injury by two different mechanisms, early in the reaction by complement and later by an unknown stimulus. Both mast cells and intact complement were also required for the full expression of neutrophil influx and release of TNF in the later phase. In fact, activated complement and mast cell mediators seemed to be the only factors necessary for the initiation of neutrophil recruitment. The findings significantly contribute to the understanding of the mechanisms involved in the induction of inflammatory processes in immune complex-mediated injury.

UI MeSH Term Description Entries
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003182 Complement C5 C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX. C5 Complement,Complement 5,Complement C5, Precursor,Complement Component 5,Precursor C5,Pro-C5,Pro-complement 5,C5, Complement,C5, Precursor,C5, Precursor Complement,Complement, C5,Component 5, Complement,Precursor Complement C5,Pro C5,Pro complement 5
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D001183 Arthus Reaction A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis. Arthus Phenomenon,Phenomenon, Arthus,Reaction, Arthus
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015550 Cell Degranulation The process of losing secretory granules (SECRETORY VESICLES). This occurs, for example, in mast cells, basophils, neutrophils, eosinophils, and platelets when secretory products are released from the granules by EXOCYTOSIS. Degranulation, Cell

Related Publications

B F Ramos, and Y Zhang, and B A Jakschik
June 1964, Zeitschrift fur Immunitats- und Allergieforschung,
B F Ramos, and Y Zhang, and B A Jakschik
August 1961, Nederlands tijdschrift voor geneeskunde,
B F Ramos, and Y Zhang, and B A Jakschik
October 1998, Naunyn-Schmiedeberg's archives of pharmacology,
B F Ramos, and Y Zhang, and B A Jakschik
October 1978, Agents and actions,
B F Ramos, and Y Zhang, and B A Jakschik
September 2012, Journal of dermatological science,
B F Ramos, and Y Zhang, and B A Jakschik
May 1998, Clinical and experimental immunology,
B F Ramos, and Y Zhang, and B A Jakschik
January 2014, Toxicon : official journal of the International Society on Toxinology,
B F Ramos, and Y Zhang, and B A Jakschik
December 1992, The Journal of pharmacology and experimental therapeutics,
B F Ramos, and Y Zhang, and B A Jakschik
October 1984, Agents and actions,
Copied contents to your clipboard!